Antibody-drug conjugates (ADCs) are targeted therapeutics designed to deliver a highly potent cytotoxic agent to tumor cells. Each ADC contains three components: a monoclonal antibody (mAb) targeting a tumor-associated antigen, a highly potent cytotoxic agent, and a chemical linker connecting the antibody and the drug. In this way, the ADC serves as a "guided missile" and selectively targets tumor cells while avoiding exposure to healthy tissue.
Mindy Mindy Hausler
Über Mindy Mindy Hausler
